EVALUATING EOSINOPHILS AS PHARMACODYNAMIC BIOMARKERS OF MEPOLIZUMAB AND RESLIZUMAB FOR PATIENTS WITH EOSINOPHILIC ASTHMA.

被引：0
|
作者：
Gershuny, V. [1 ]
Florian, J. [1 ]
Wang, Y. [1 ]
Strauss, D. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIV-003
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [21] RESLIZUMAB IMPROVES SPIROMETRIC LUNG AGE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Carr, W.
    McDonald, M.
    Meizlik, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S57 - S57
  • [22] Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
    Shimoda, Terufumi
    Odajima, Hiroshi
    Okamasa, Arisa
    Kawase, Minako
    Komatsubara, Masaki
    Mayer, Bhabita
    Yancey, Steven
    Ortega, Hector
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (03) : 445 - 451
  • [23] Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
    Takanori Numata
    Katsutoshi Nakayama
    Hirofumi Utsumi
    Kenji Kobayashi
    Haruhiko Yanagisawa
    Mitsuo Hashimoto
    Shunsuke Minagawa
    Takeo Ishikawa
    Hiromichi Hara
    Jun Araya
    Kazuyoshi Kuwano
    BMC Pulmonary Medicine, 19
  • [24] Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
    Shrimanker, Rahul
    Hargaden, B.
    Bradding, P.
    Wardlaw, A. J.
    Brightling, C. E.
    Green, R.
    Bafadhel, M.
    Heaney, L.
    Pavord, I.
    Haldar, P.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [25] Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
    Numata, Takanori
    Nakayama, Katsutoshi
    Utsumi, Hirofumi
    Kobayashi, Kenji
    Yanagisawa, Haruhiko
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [26] IMPACT OF WEIGHT ON THE EFFICACY OF MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Ortega, H.
    Albers, F.
    Llanos-Ackert, J.
    Bradford, E.
    Price, R.
    Pouliquen, I.
    Castro, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : E3 - E4
  • [27] Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma
    Erro Iribarren, Marta
    Cisneros Serrano, Carolina
    Acosta Gutierrez, Carmen Maria
    Roca Noval, Ana
    Martinez Meca, Ana
    Garcia Castillo, Elena
    Hernandez Olivo, Marta
    Soriano, Joan B.
    Ancochea Bermudez, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [28] Efficacy Of Mepolizumab In Patients With Severe Eosinophilic Asthma And Nasal Polyps
    Liu, Mark C.
    Keene, Oliver N.
    Yancey, Steven W.
    Bratton, Daniel J.
    Albers, Frank C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB8 - AB8
  • [29] A Real World, Single Center Experience of Treatment of Severe Eosinophilic Asthma with IL-5 Antagonists; Mepolizumab and Reslizumab
    Mylvaganam, R.
    Rogers, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [30] Efficacy of Reslizumab Treatment in Exacerbation-Prone Patients with Severe Eosinophilic Asthma
    Wechsler, Michael E.
    Hickey, Lisa
    Garin, Margaret
    Chauhan, Anoop
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (10): : 3434 - +
12345